BPC-157/TB500

BPC-157/TB-500 — nicknamed the "Wolverine Stack" in research circles — combines BPC-157, a synthetic pentadecapeptide fragment derived from a sequence found in human gastric juice, with TB-500, a synthetic peptide built around the actin-binding domain of Thymosin Beta-4 (Tβ4). The pairing is studied in preclinical tissue-repair research for its proposed complementary mechanisms: BPC-157's angiogenic and cytoprotective signaling alongside TB-500's actin-mediated cell-migration and remodeling activity.
Studied for (preclinical / in vitro research):
• Angiogenesis and VEGFR2 pathway activation in rodent tendon and ligament injury models (BPC-157 component)
• G-actin sequestration and cytoskeletal reorganization supporting directed cell migration in wound-healing models (TB-500 component)
• Achilles tendon transection research showing increased tensile strength and higher collagen-I:III ratio with combined administration versus BPC-157 alone (rat models, Sikiric lab)
• Gastrointestinal mucosal and epithelial repair mechanisms in rodent injury models (BPC-157 component)
• Dermal wound re-epithelialization research associated with the Thymosin Beta-4 actin-binding domain (TB-500 component)
• Nitric oxide (NO) signaling pathway interactions in vascular research models
• Integrin-linked kinase signaling and progenitor-cell recruitment in tissue-remodeling studies

For Laboratory Research Use Only. Not for human or veterinary use. Not a drug, dietary supplement, or cosmetic. Not intended to diagnose, treat, cure, or prevent any disease. Not for in-vivo use of any kind outside of a controlled research setting. Keep out of reach of children. By purchasing, you certify that you are a qualified researcher or research institution acquiring this product solely for in vitro laboratory research, and that you accept sole responsibility for compliance with all applicable local, state, and federal laws and regulations.